Oklo has announced its acquisition of Atomic Alchemy for $25 million in an all-stock deal, aiming to expand its presence in the $55.7 billion radioisotope market. This strategic move is intended to address supply shortages in both medical and industrial applications. The acquisition will leverage Oklo's fast reactor technology, which is expected to support semiconductor doping and create new revenue streams for the company. Additionally, Oklo is reportedly in discussions to provide 750 megawatts of nuclear-waste-powered small reactors to data centers, responding to increasing electricity demands driven by factories and AI operations. However, Oklo's stock has faced challenges, declining by 25% recently following a reported loss and amid broader market pressures affecting nuclear stocks.
Utility Entergy is in talks with some of its biggest customers about deploying small nuclear reactors as electricity demand surges from factories and AI data centers https://t.co/7A7mdPkDHv
Utility Entergy is in talks with some of its biggest customers about deploying small nuclear reactors as electricity demand surges from factories and AI data centers https://t.co/ZPrFOhlExf
Nuclear reaction. $OKLO, a small company backed by Sam Altman, down 25% today after reporting another loss. Nuclear stocks have been hit lately after regulators rejected $TLN $AMZN deal. I wrote about Oklo for @barronsonline last month ICYMI. https://t.co/HRkn1ETpBr